MwanzoREGN34 • BVMF
add
Regeneron Pharmaceuticals Inc BDR
Bei iliyotangulia
R$ 58.12
Bei za siku
R$ 52.26 - R$ 57.00
Bei za mwaka
R$ 52.26 - R$ 111.62
Thamani ya kampuni katika soko
62.20B USD
Wastani wa hisa zilizouzwa
955.00
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 3.79B | 10.33% |
Matumizi ya uendeshaji wa biashara | 792.20M | 7.46% |
Mapato halisi | 917.70M | -20.86% |
Kiwango cha faida halisi | 24.22 | -28.28% |
Mapato kwa kila hisa | 12.07 | 1.77% |
EBITDA | 1.15B | 2.69% |
Asilimia ya kodi ya mapato | 4.22% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 9.01B | -16.90% |
Jumla ya mali | 37.76B | 14.15% |
Jumla ya dhima | 8.41B | 18.27% |
Jumla ya hisa | 29.35B | — |
hisa zilizosalia | 107.02M | — |
Uwiano wa bei na thamani | 0.21 | — |
Faida inayotokana na mali | 6.78% | — |
Faida inayotokana mtaji | 7.92% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 917.70M | -20.86% |
Pesa kutokana na shughuli | 1.26B | 15.89% |
Pesa kutokana na uwekezaji | 350.60M | 629.61% |
Pesa kutokana na ufadhili | -1.14B | -154.54% |
Mabadiliko halisi ya pesa taslimu | 477.20M | -17.38% |
Mtiririko huru wa pesa | 936.12M | 70.83% |
Kuhusu
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1988
Makao Makuu
Tovuti
Wafanyakazi
15,106
